What Is the Difference Between Patentability and Freedom to Operate?

The difference between patentability and freedom to operate is that patentability asks whether you can get a patent on your invention, while freedom to operate, or FTO, asks whether you can make, use and sell your product without infringing someone else’s patent. The two searches look for different documents, read them differently and usually happen at different stages of a product’s life, so a clean result on one says very little about the other. We hear the terms used interchangeably in board meetings and term sheets, and now and then by lawyers, which is how this page came to be written.

At a Glance

  • Patentability: Can you get a patent? A patentability study compares your invention with everything made public before your filing date.
  • Freedom to operate: Can you sell without infringing? An FTO search compares your product with the claims of live patents and pending applications in the countries where you will sell.
  • Timing: We run a patentability study before drafting every application; FTO work usually follows a prototype, when an investor, partner or client asks for it.
  • Different results: A clean result on one search says very little about the other.
  • Shared blind spot: Most applications publish about 18 months after their earliest filing date, so recent filings are invisible to both searches.

Part of the confusion comes from what a patent gives you. As the USPTO explains, a patent gives its owner the right to stop others from making, using, selling or importing the invention. It gives the owner no right to practice the invention. Your improved formulation or faster inference method can be patentable and still fall inside someone else’s broader patent on the underlying compound or model architecture. Both patents can be valid at the same time, and neither owner can sell the improved version without the other’s cooperation. Our FAQ on licensing to improve a patented device, drug or diagnostic covers that situation in more detail.

What Does a Patentability Study Tell You?

A patentability study tells you whether your invention is likely patentable and how broadly it can be claimed. The study, sometimes called a patentability search, compares the invention with everything made public before your filing date. It asks whether the invention is new, meaning no single earlier document describes it. It also asks whether the invention would have been obvious to a skilled scientist or engineer who knew the earlier material, including by combining two or three earlier documents. Where it matters, the study asks whether the subject matter can be patented at all, which is a live question for software, diagnostic methods and products found in nature.

The results shape the patent application. If nothing close turns up, we can claim broadly. A close reference shows us where the line is, so we can draw the claims just past it and explain in the application why the difference matters. The study also flags the company’s own talks, preprints and posters. The U.S. gives inventors a one-year grace period for their own disclosures, while Europe and most other countries generally do not, so a paper published before filing can cost foreign rights even when the U.S. application is safe.

What Does a Freedom-to-Operate Search Tell You?

A freedom-to-operate search tells you whether a specific product is likely to infringe a live patent. An FTO search starts from the product you actually intend to make and sell, in the countries where you intend to make and sell it. It looks for patents and patent applications that are, or could become, enforceable in those countries. Then it compares your product against their claims, the numbered sentences at the end of each patent that define what it covers. A product infringes a patent if it falls within any single claim; it does not have to match the whole patent or even the claim the owner considers most important.

The result is a risk assessment for one product in the named countries as of a particular date. It usually comes in two stages. A search identifies the patents worth worrying about. Patent counsel then writes an opinion that reads each patent’s claims the way a court would and explains why the product does or does not fall within them, or why the patent is likely invalid.

FTO searching also starts from the companies most likely to assert a patent. We look at competitors’ and licensors’ portfolios and, for drugs and biologics, the patents listed with the FDA in the Orange Book and the Purple Book patent lists. A patentability search almost never asks who owns what.

When Should You Run a Patentability Study or an FTO Search?

A patentability study comes before the patent application is drafted, and an FTO search usually comes after a prototype exists and before launch. We run a patentability study on every invention before we draft. The client receives the findings, but the study{a}s main job is to show us how broadly we can claim. At the disclosure stage, the study often turns up more than one invention, usually a product and a method of using it, and sometimes a manufacturing process or a new use that deserves its own claims.

FTO work usually comes later, when someone asks for it. Most often that is an investor during diligence or a partner before a supply or license deal. Sometimes it is the client, who wants assurance that a product is clear before launch. By then there is usually a proof of concept or a prototype and a mostly settled design, so the search can target what will actually ship instead of the idea described in the original disclosure. The narrower target is what turns up the most pertinent patents, and it is why an FTO search run too early tends to be expensive and inconclusive.

Why Do FTO References Differ From Patentability References?

Patentability and FTO searches can start in the same databases and come back with very different lists, because they treat age, document content, product coverage and vocabulary differently.

Patentability Study and FTO Search Compared

Patentability studyFTO search
QuestionCan you get a patent on the invention?Can you make, use and sell the product without infringing?
Starts fromThe invention disclosureThe product as it will ship, in the countries where it will be sold
What countsAnything made public before the filing date, however old and in whatever languagePatents and applications that are, or could become, enforceable in the named countries
Part of each document readThe whole disclosure, including examples and figuresThe claims, with the rest read only to interpret them
Expired patentsStill prior artHarmless, unless a live patent covers the same thing
Journal articlesCan defeat a patent applicationCannot block a launch, because they have no claims
Usual timingBefore draftingAfter a prototype, before launch, or in diligence
ResultA claim strategyA dated risk assessment for one product
Each row is explained in the sections that follow.

Age cuts in opposite directions. A patentability search is deliberately wide. Anything made public before the filing date counts, however old and in whatever language, from patents and journal articles to preprints, theses and conference posters. An AI system that delivers the same result as a 1972 IBM patent can look to an examiner like an obvious upgrade of an old idea, even when the inventor knows the difference is night and day. Finding that IBM patent early lets us claim, and explain, what actually changed. For FTO, the same patent expired decades ago and is harmless, because whatever an expired patent covered is free for everyone to use, as long as no unexpired patent covers it too.

The searches also read different parts of each document. A patentability search reads the whole disclosure of each reference, including examples and figures, because anything a document teaches can count against a new application. An FTO search reads the claims and looks at the rest of the patent only to interpret what the claims mean. A journal article can sink a patent application, yet it can never block a product launch, because it has no claims.

Coverage differs too. A patentability search focuses on what is new about the invention. An FTO search has to cover the whole product, including ordinary parts that a patentability search skips because nothing about them is new. The excipient in a formulation counts, and so do the chromatography step in a purification process and the scheduling method in an AI serving stack. When the product is a known improvement on a known base technology and the base patents have expired or are licensed, the FTO work stays contained. It gets harder when the base technology itself is crowded with live patents.

Then there is vocabulary. Patentability searching follows the inventor’s words and the terms used in the current literature. FTO searching has to follow the words patent drafters used ten or fifteen years ago, and patent drafters, ourselves included, like to describe a function in the broadest terms an examiner will allow. A claim can also reach a product it does not literally describe if the product uses an equivalent, meaning a substitute that does substantially the same job in substantially the same way to get substantially the same result. In Warner-Jenkinson v. Hilton Davis, the Supreme Court held that equivalence is judged at the time of infringement, not when the patent issued, so technology that did not exist when the patent was written can still be caught. Equivalents have limits. They cannot stretch a claim to cover what was already public before the patent was filed, and arguments or amendments the owner made to get the patent can narrow them. A patentability search aims at the invention, so it rarely finds this kind of match.

Why Do Patent Status, Families and Territory Matter for FTO?

Patent status, patent families and territory matter for FTO because only a live patent in a country where you sell can be enforced against you, and a patentability search can skip all three. An FTO search checks the legal status of every patent it finds; a patentability search does not need to, because an expired patent is prior art all the same. A U.S. patent lapses early if its maintenance fees go unpaid, although a lapsed patent can sometimes be revived, so a lapse is good news with a footnote. A patent may carry a terminal disclaimer, a statement filed during examination that ties its expiration to an earlier patent in the same family. Drug and biologic patents can run past the usual twenty years through U.S. extensions that restore part of the time lost to FDA review, and through supplementary protection certificates in Europe. An FTO opinion needs each patent’s actual expiration date, which can fall well before or well after the twentieth anniversary of filing.

The search also follows each patent’s whole family. A granted patent may have pending continuations, later applications that share the original description and can still issue new claims, sometimes drafted with a competitor’s product in view, as long as the original description supports them. The same family can claim different things in different countries. A U.S. patent may claim more broadly than its European counterpart, or the reverse, so a reference that matters in one market can be irrelevant in the next. Patents are territorial, and an FTO opinion covers only the countries it names.

Should an FTO Search Include Published Applications?

Yes. An FTO search should include published patent applications along with granted patents, even for a U.S.-only opinion. Looking only at granted patents gives a snapshot that can be out of date within months, because pending claims can still be amended to reach a product on the market. In the U.S., a patent that issues from a published application can, in some cases, also collect a royalty going back to the publication date, so waiting for the grant before paying attention can be an expensive habit.

Patentability and FTO searches share one blind spot. Most applications publish about 18 months after their earliest filing date, so anything filed in the last year and a half is usually invisible to everyone. A competitor’s earlier-filed application can count against your patent once it publishes, even though no search could have found it on the day you filed. On the FTO side, the blind spot means every clean opinion carries a date. We refresh it before launch, after a meaningful design change and when a competitor application we are tracking publishes or is allowed.

What Happens When an FTO Search Finds a Close Patent?

When an FTO search turns up a patent that looks close, the next step is often a validity search, which is a patentability search pointed at someone else’s patent. Its goal is to find older material showing that the patent’s claims should never have been granted as written. From there, the options are familiar: design the product around the claims, take a license, challenge the patent at the USPTO or in court, wait for it to expire, or document a reasoned position that the product does not infringe. Which one makes sense depends on the patent’s strength, the owner, the timeline and how much of the product’s value sits inside the claims.

How Does Freedom to Operate Work for Drugs, Biologics, Manufacturing and AI?

Freedom to operate for drugs, biologics, manufacturing and AI turns on a different question in each case: which patents survive to launch day, where and how the product is made, and how a model is used. Drug and biologic developers get some breathing room. U.S. law shields development work reasonably related to FDA submissions, and in Merck v. Integra the Supreme Court read that shield to include preclinical studies, even when the results never reach the FDA. The shield ends at commercial sale. Pharmaceutical FTO work therefore centers on which patents will still be in force on launch day, and it has to be done early enough to change the plan if the answer is bad.

Manufacturing adds its own layer. Process patents cover how a product is made, and importing into the U.S. a product made abroad by a process patented in the U.S. can infringe here. A CDMO technology transfer is a natural point to check the process as well as the product.

AI developers have no comparable shield. Running a patented method on your own servers is still use, even if the only witness is a GPU. Once a model ships through an API or an open-weight release, the question can also become whether the company encouraged customers to practice a patented method, which turns on what the company knew and what it told users to do.

What Does an FTO Opinion Add to a Search Report?

An FTO opinion adds patent counsel’s reasoned conclusions to a search report, which by itself is only a list of documents. The opinion explains what those documents mean for your product and why, and that matters in U.S. litigation. After Halo Electronics v. Pulse Electronics, courts have more room to increase damages, up to triple, for egregious, knowing infringement. Under 35 U.S.C. 298, a company’s failure to get an opinion, or its decision not to show one in court, cannot be used to prove willful infringement or intent to induce infringement, so no company is required to get one. A well-reasoned opinion obtained before launch is still good evidence that the company acted in good faith. The catch is that a company relying on the opinion in court usually waives attorney-client privilege on the same subject, so the opinion should be written on the assumption that the other side will read it.

In Europe, the larger risk is an injunction. Since June 2023, the Unified Patent Court can stop sales across many EU countries in a single action, which makes European FTO a launch question as much as a damages question.

Common Questions About Patentability and Freedom to Operate

Is a patentability study the same as a freedom-to-operate search?

No. A patentability study asks whether your invention can be patented, while a freedom-to-operate search asks whether your product can be made and sold without infringing someone else’s live patent claims, and a clean result on one says very little about the other.

Can I get a patent and still infringe someone else’s patent?

Yes. A patent gives its owner the right to stop others, not the right to practice the invention, so an improvement can be patentable and still fall inside someone else’s broader patent.

When should a company get an FTO opinion?

A company usually gets an FTO opinion once there is a prototype or a mostly settled design, often because an investor or partner asks for it in diligence, and refreshes it before launch and after meaningful design changes.

Does a U.S. FTO search need to include published applications?

Yes. Pending claims can still be amended to reach a product already on the market, so even a U.S.-only FTO search should cover published applications as well as granted patents.

Related FAQs

Celebrate a clean patentability study, then give the launch a search of its own. If a filing, a launch or a financing is on the calendar and you’re not sure which search you need, talk to us.

This FAQ provides general information, not legal advice, and does not create an attorney-client relationship. Outcomes depend on specific facts and jurisdictions. See our Legal Notices.